Clinical Trial Update: Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating anti-tumor activity of (177Lu) rhPSMA-10.1 injection in prostate cancer, including metastatic castration-resistant disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• (177Lu) rhPSMA-10.1 injection (Lutetium-177-labeled rhPSMA-10.1)

Snippet

Sponsor: Blue Earth Therapeutics Ltd | Conditions: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING